scholarly journals Scleral perforation involving the papillomacular bundle secondary to peribulbar anaesthetic injection

2020 ◽  
Vol 18 ◽  
pp. 100657
Author(s):  
Edward Bloch ◽  
Mohsan Malik ◽  
Gaurav Bhardwaj ◽  
Andrew Scott
2020 ◽  
Vol 78 (6) ◽  
pp. 445-453
Author(s):  
Priscila de Camargo Smolarek ◽  
Leonardo Siqueira da Silva ◽  
Paula Regina Dias Martins ◽  
Karen da Cruz Hartman ◽  
Marcelo Carlos Bortoluzzi ◽  
...  

2020 ◽  
pp. 112067212096345
Author(s):  
Edward Bloch ◽  
Lyndon da Cruz

Introduction: Juxtapapillary laser (JPL) photocoagulation in the region of the papillomacular bundle, temporal to the optic nerve, has become routine care in disorders such as optic disc pit maculopathy. Despite evidence demonstrating safe and effective use of this approach, there is still a lack of consensus in the literature, due to the perceived risk of loss of visual function. Instances of such misplaced caution could result in inadequate treatment protocols. Methods: An observational series of five cases of optic disc pit maculopathy, treated with dense temporal juxtapapillary endolaser, in a single tertiary ophthalmic hospital. Results: None of the reported cases of optic disc pit maculopathy treated with dense juxtapapillary laser demonstrated anatomical or perimetric findings consistent with nerve fiber layer damage in the region of the papillomacular bundle. Conclusions: This series demonstrates that dense laser photocoagulation, in the vicinity of the papillomacular bundle, does not cause structural damage to the nerve fiber layer or associated loss of visual function in optic disc pit maculopathy. Appropriate application of juxtapapillary laser is a safe and effective treatment for various macular pathologies.


1999 ◽  
Vol 54 (7) ◽  
pp. 430-433 ◽  
Author(s):  
Joseph E Odoom ◽  
Georgina M Allen ◽  
David J Wilson

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Aloka Samantaray ◽  
Mangu Hanumantha Rao ◽  
Chitta Ranjan Sahu

We aimed to show that a single preprocedural dose of either dexmedetomidine or fentanyl reduces procedural pain and discomfort and provides clinically acceptable sedation. In this prospective, double-blind study, sixty patients scheduled for elective surgery and requiring planned central venous catheter insertion were randomized to receive dexmedetomidine (1 μg/kg), fentanyl (1 μg/kg), or 0.9% normal saline intravenously over ten minutes followed by local anesthetic field infiltration before attempting central venous catheterization. The primary outcome measures are assessment and analysis of pain, discomfort, and sedation level before, during, and after the central venous catheter insertion at five time points. The median (IQR) pain score is worst for normal saline group at local anaesthetic injection [6 (4–6.7)] which was significantly attenuated by addition of fentanyl [3 (2–4)] and dexmedetomidine [4 (3–5)] in the immediate postprocedural period (P=0.001). However, the procedure related discomfort was significantly lower in dexmedetomidine group compared to fentanyl group in the first 10 min of procedure after local anaesthetic Injection (P=0.001). Fentanyl is more analgesically efficient for central venous catheter insertion along with local anaesthetic injection. However, dexmedetomidine has the potential to be superior to fentanyl and placebo in terms of providing comfort to the patients during the procedure.


Sign in / Sign up

Export Citation Format

Share Document